Financhill
Sell
29

JANX Quote, Financials, Valuation and Earnings

Last price:
$14.72
Seasonality move :
87.58%
Day range:
$13.46 - $15.28
52-week range:
$12.80 - $47.58
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
91.81x
P/B ratio:
0.93x
Volume:
6.2M
Avg. volume:
2.2M
1-year change:
-62.32%
Market cap:
$910.6M
Revenue:
$10.6M
EPS (TTM):
-$1.68

Earnings Data

Next earnings date for JANX
Feb 26
2026
Most recent earnings per share
-$0.39
Beat by $0.22
(Nov 6/2025)
Consensus Estimate
-$0.61
(Nov 6/2025)

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

JANX Quarterly Earnings History

Date Quarter Revenue Forecast Actual Revenue Reported EPS Consensus EPS Beat/Miss
03/31/2026 Q1 $850K -- -- -$0.71 --
02/26/2026 Q4 $71.4K -- -- -$0.64 --
11/06/2025 Q3 $3.1M $10M -$0.39 -$0.61 $0.22
08/07/2025 Q2 $272.7K -- -$0.55 -$0.47 -$0.08
05/08/2025 Q1 $650K -- -$0.38 -$0.39 $0.01
12/31/2024 Q4 $1.3M -- -$0.36 -$0.45 $0.10
11/06/2024 Q3 $1.6M $439K -$0.51 -$0.36 -$0.16
08/07/2024 Q2 $863.1K $8.9M -$0.11 -$0.29 $0.18
05/08/2024 Q1 $1M $1.3M -$0.30 -$0.33 $0.03
03/08/2024 Q4 $739.3K $2.5M -$0.25 -$0.39 $0.14
11/07/2023 Q3 $845.5K $2.5M -$0.25 -$0.43 $0.18
08/08/2023 Q2 -- $1.1M -$0.42 -- --
05/09/2023 Q1 -- $2M -$0.42 -- --
03/10/2023 Q4 -- $2.8M -$0.39 -- --
11/10/2022 Q3 -- $1.8M -$0.40 -- --
08/09/2022 Q2 -- $2.4M -$0.41 -- --
05/10/2022 Q1 -- $1.6M -$0.32 -- --
03/18/2022 Q4 -- $1.6M -$0.33 -- --
11/09/2021 Q3 -- $1.2M -$0.26 -- --
08/10/2021 Q2 -- $482K -$0.15 -- --
03/31/2021 Q1 -- $380K -$0.05 -- --
12/31/2020 Q4 -- -- -$0.13 -- --
09/30/2020 Q3 -- -- -$0.03 -- --
06/30/2020 Q2 -- -- -$0.06 -- --
03/31/2020 Q1 -- -- -$0.03 -- --

Janux Therapeutics, Inc. Earnings Questions

  • How Much did Janux Therapeutics, Inc. Generate in Revenue Last Quarter?

    Janux Therapeutics, Inc. reported $10M worth of top line sales in its most recent quarter.

  • Did Janux Therapeutics, Inc. Beat Earnings Last Quarter?

    Janux Therapeutics, Inc. announced earnings per share of -$0.39 which represents a beat of analyst forecast a -$0.61 per share.

  • Is Janux Therapeutics, Inc. Profitable?

    Janux Therapeutics, Inc. reported $9.5M that represents $0.15 per share over the last quarter.

  • What is the Analyst Consensus for Janux Therapeutics, Inc. EPS Next Year?

    Janux Therapeutics, Inc.'s earnings are forecast to decrease from -$1.28 per share to -$1.97 per share next year representing a decrease of -131.65%.

  • When is Janux Therapeutics, Inc.'s Earnings Date?

    Janux Therapeutics, Inc.'s next earnings date is February 26, 2026.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Why Did SoundHound AI Stock Go Up?
Why Did SoundHound AI Stock Go Up?

SoundHound AI (NASDAQ:SOUN) has moved higher in recent days, breaking…

Is Goldman Sachs Going to Go Up?
Is Goldman Sachs Going to Go Up?

Shares of financial giant Goldman Sachs (NYSE:GS) have soared by…

How High Will MSTR Stock Go?
How High Will MSTR Stock Go?

After several months of pressure, shares of Bitcoin treasury Strategy…

Stock Ideas

Buy
57
Is NVDA Stock a Buy?

Market Cap: $4.5T
P/E Ratio: 63x

Buy
59
Is GOOG Stock a Buy?

Market Cap: $4T
P/E Ratio: 41x

Sell
48
Is GOOGL Stock a Buy?

Market Cap: $4T
P/E Ratio: 41x

Alerts

Buy
69
INTC alert for Jan 23

Intel Corp. [INTC] is down 17.36% over the past day.

Buy
51
APGE alert for Jan 23

Apogee Therapeutics, Inc. [APGE] is down 10.41% over the past day.

Buy
70
BNR alert for Jan 23

Burning Rock Biotech Ltd. [BNR] is down 13.78% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock